Sequence of Radiation and Targeted Therapy in Brain Metastases

Clinical trial NCT04832672 · COMPLETED

Trial details

NCT number: NCT04832672
Sponsor: Chinese Academy of Medical Sciences
Status: COMPLETED
Study type: OBSERVATIONAL

The Optimal Sequence of Radiotherapy and Systematic Tyrosine Kinase Inhibitors in Treating Brain Metastases

Start date: 2010-10-01
Primary completion: 2021-03-01
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.